News 14/16

FDA approved AbbVie’s Rinvoq for treatment of moderately to severe rheumatoid arthritis

ipharmaservices

Aug 16, 2019

National Medical Products Administration in China approved Gilead’s Biktarvy for HIV-1 infection

ipharmaservices

Aug 10, 2019

GSK and Pfizer combine to establish a world-leading consumer healthcare venture

ipharmaservices

Aug 3, 2019

Biosimilars of Avastin and Herceptin are approved in the United States

ipharmaservices

Jul 18, 2019

Eli Lilly's Olumiant approved by TGA in Australia for moderate to severe rheumatoid arthritis

ipharmaservices

Jul 18, 2019

EiSai’s Halaven approved in China for treatment of locally advanced or metastatic breast cancer

ipharmaservices

Jul 17, 2019

US FDA approved Merck's Recarbrio for adults with cUTI and cIAI

ipharmaservices

Jul 17, 2019

AbbVie acquires Mavupharma, making its oncology pipeline stronger

ipharmaservices

Jul 17, 2019

Novartis SEG101 (crizanlizumab) received priority review from US FDA

ipharmaservices

Jul 17, 2019

Johnson & Johnson announces a new public-private partnership for the development of HIV Vaccine

ipharmaservices

Jul 16, 2019

NOVARTIS RELEASE MULTIPLE TRIAL RESULTS OF COSENTYX IN JUNE

ipharmaservices

Jun 30, 2019

Dupixent approved for chronic rhinosinusitis with nasal polyposis in United States

ipharmaservices

Jun 29, 2019

Pfizer’s receives approval for Avastin’s biosimilar from FDA

ipharmaservices

Jun 28, 2019

FDA approved AMAG Pharmaceuticals’ Vyleesi, expanded the indication of Symdeko for patients with CF

ipharmaservices

Jun 23, 2019

Roche’s Rozlytrek approved for the NTRK fusion-positive advanced recurrent solid tumors in Japan

ipharmaservices

Jun 23, 2019

Pfizer’s Talzenna was approved in Europe for the treatment of inherited BRCA-Mutated breast cancer

ipharmaservices

Jun 23, 2019

Novo Nordisk’s Esperoct approved for hemophilia in European Union

ipharmaservices

Jun 21, 2019

New guidance issued by CMC to safeguard and maintain the integrity of Medicaid enrollees

ipharmaservices

Jun 21, 2019

Janssen reports Phase 3 trials of Tremfya in adult patients with psoriatic arthritis

ipharmaservices

Jun 16, 2019

GSK and University of California collaborate to conduct advanced genomic research

ipharmaservices

Jun 14, 2019

iPharmaCenter

ipharmacenter Consulting services

FDA approved AbbVie’s Rinvoq for treatment of moderately to severe rheumatoid arthritis

National Medical Products Administration in China approved Gilead’s Biktarvy for HIV-1 infection

GSK and Pfizer combine to establish a world-leading consumer healthcare venture

Biosimilars of Avastin and Herceptin are approved in the United States

Eli Lilly's Olumiant approved by TGA in Australia for moderate to severe rheumatoid arthritis

EiSai’s Halaven approved in China for treatment of locally advanced or metastatic breast cancer

US FDA approved Merck's Recarbrio for adults with cUTI and cIAI

AbbVie acquires Mavupharma, making its oncology pipeline stronger

Novartis SEG101 (crizanlizumab) received priority review from US FDA

Johnson & Johnson announces a new public-private partnership for the development of HIV Vaccine

NOVARTIS RELEASE MULTIPLE TRIAL RESULTS OF COSENTYX IN JUNE

Dupixent approved for chronic rhinosinusitis with nasal polyposis in United States

Pfizer’s receives approval for Avastin’s biosimilar from FDA

FDA approved AMAG Pharmaceuticals’ Vyleesi, expanded the indication of Symdeko for patients with CF

Roche’s Rozlytrek approved for the NTRK fusion-positive advanced recurrent solid tumors in Japan

Pfizer’s Talzenna was approved in Europe for the treatment of inherited BRCA-Mutated breast cancer

Novo Nordisk’s Esperoct approved for hemophilia in European Union

New guidance issued by CMC to safeguard and maintain the integrity of Medicaid enrollees

Janssen reports Phase 3 trials of Tremfya in adult patients with psoriatic arthritis

GSK and University of California collaborate to conduct advanced genomic research